Comments
The US FDA has approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose levels and provide appropriate basal insulin doses in people aged 14 and above, with type 1 diabetes.
The MiniMed 670G, often referred to as an “artificial pancreas,” is intended to adjust insulin levels with little or no input from the user. It measures glucose levels every five minutes and automatically administers or withholds insulin.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.